VarCov Co’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$418K Buy
+6,338
New +$483K 0.2% 178
2026
Q2
– Sell
-7,805
Closed -$514K – 412
2026
Q1
$514K Buy
7,805
+1,792
+30% +$114K 0.19% 203
2025
Q4
$382K Buy
+6,013
New +$374K 0.15% 233

Other funds holding CYTK

VarCov Co's CYTK Position: Q3 2026 in Review

VarCov Co opened a new position in Cytokinetics (CYTK) in Q3 2026: 6,338 shares worth $418K. The stake represents 0.2% of the portfolio and ranks #178 among its holdings. This is a return to the name: VarCov Co previously reported a position in CYTK as recently as Q1 2026.

VarCov Co first reported a position in CYTK in Q4 2025 and has held it in 3 quarters since. The position peaked at $514K in Q1 2026. 472 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • VarCov Co held 6,338 shares of Cytokinetics worth $418K as of Q3 2026.
  • Cytokinetics was a new VarCov Co position in Q3 2026.
  • Cytokinetics made up 0.2% of VarCov Co's portfolio in Q3 2026, its #178 holding.
  • VarCov Co first reported a position in Cytokinetics in Q4 2025 and has held it in 3 quarters since.
  • VarCov Co's Cytokinetics position peaked at $514K in Q1 2026.
  • 472 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.